The present invention is based on the surprising and unexpected finding that the ratio of the C/C genotype of -509 C/T TGF-β1 polymorphisms is higher among patients with post-traumatic tracheal scar tissue. Therefore, the determination of this polymorphism offers a good possibility to forecast susceptibility to the development of post-traumatic tracheal scar tissue.
The new DNA kit is able to use in that cases where post traumatic scar tissue can evolve. Especially intubated patients.
Benefits of the invention:
— early stage diagnostic of post-traumatic tracheal scar tissue
— patient-friendly method
— opportunity for prophylaxis
— easy and simple way to diagnose accurately
economical to use